In China, doctors are treating more and more cancer patients with the gene-editing tool known as CRISPR. But research on the technique is still limited.
TGen Helps Develop New Test To Diagnose Valley Fever
Doctors treating patients they suspect have valley fever will soon have a new way to test for the disease.
The Translational Genomics Research Institute (TGen) along with the Utah-based company DxNA, says the FDA has cleared their new, molecular test for the ailment.
David Taus, president and CEO of DxNA, says the current test involves growing a culture, which can take up to 21 days, whereas this new test can provide an answer the same day.
That speed, he says, helps patients with expenses.